The Dantrolene Sodium Capsules, cataloged under National Stock Number 6505-01-153-3380, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Procter & Gamble Pharmaceuticals, Inc.. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-153-3380 |
| Primary Part Number | NDC00149-0030-66 |
| Item Name | Dantrolene Sodium Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Procter & Gamble Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00149-0030-66 PRIMARY | Procter & Gamble Pharmaceuticals, Inc. (USA) |
| Reference | Meaning |
|---|---|
| DANTRIUM CAPSULES | 5/1 Secondary reference Procter & Gamble Pharmaceuticals, Inc. |
| DANTRIUM | 5/1 Secondary reference Procter & Gamble Pharmaceuticals, Inc. |
NSN 6505-01-153-3380 is a Dantrolene Sodium Capsules, manufactured by Procter & Gamble Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-153-3380 has 1 manufacturer part number on file: NDC00149-0030-66 (Procter & Gamble Pharmaceuticals, Inc.).
Key specifications for NDC00149-0030-66: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000; Part Name Assigned by Controlling Agency: DANTROLENE SODIUM CAPSULES 25MG 500S BT; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.